GRI Bio Inc (GRI)

[zj3001]

Things to note that I posted on X and ST.

✅Company stated earlier this year that it will have a partner or implied buyout when positive Phase2 verified proof of concept.

✅ News last week stating positive phase 2 data has been demonstrated, study on going.

https://gribio.com/gri-bio-presents-positive-preclinical-data-demonstrating-gri-0621s-ability-to-inhibit-invariant-natural-killer-t-inkt-cell-activity-and-reduce-important-inflammatory-and-fibrotic-drivers-in-idiopa/

✅ Phase 2 expected to be done this year (2024).

https://clinicaltrials.gov/study/NCT06331624?spons=GRI%20Bio%20Operations,%20Inc.&rank=1

✅ 10-Q 8/14/24, Page 9, “Based on the Company’s current operating plan, the Company believes that its existing cash and cash equivalents will be sufficient to fund its operating expenses and capital expenditure requirements into the first quarter of 2025.”

https://s3.amazonaws.com/sec.irpass.cc/2647/0001824293-24-000105.htm



✅Nasdaq compliance due by March 2025.